Apogee Therapeutics, Inc.
APGE
$38.76
$2.416.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -66.10M | -55.34M | -67.22M | -49.02M | -33.82M |
| Total Depreciation and Amortization | 399.00K | 207.00K | 76.00K | 48.00K | 36.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.51M | 9.60M | 5.38M | 2.72M | 2.94M |
| Change in Net Operating Assets | -6.84M | -2.95M | -5.96M | 3.73M | 1.54M |
| Cash from Operations | -62.03M | -48.48M | -67.71M | -42.52M | -29.30M |
| Capital Expenditure | -768.00K | -4.32M | 1.00K | -751.00K | -51.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 78.89M | 17.30M | 46.37M | -145.63M | -148.66M |
| Cash from Investing | 78.13M | 12.98M | 46.37M | -146.38M | -148.71M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.18M | 622.00K | 44.36M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -32.66M | -150.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 33.05M | -- |
| Cash from Financing | 1.18M | 622.00K | 44.36M | 383.00K | -150.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.28M | -34.87M | 23.01M | -188.52M | -178.16M |